These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34048233)

  • 1. Discovery of a Potent and Selective Chikungunya Virus Envelope Protein Inhibitor through Computer-Aided Drug Design.
    Battini L; Fidalgo DM; Álvarez DE; Bollini M
    ACS Infect Dis; 2021 Jun; 7(6):1503-1518. PubMed ID: 34048233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
    Verma J; Hasan A; Sunil S; Subbarao N
    J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein.
    Verma J; Subbarao N
    J Biomol Struct Dyn; 2023 May; 41(8):3349-3367. PubMed ID: 35272566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry.
    Sahoo B; Chowdary TK
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry.
    Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE
    Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Docking Studies to Explore Potential Binding Pockets and Inhibitors for Chikungunya Virus Envelope Glycoproteins.
    Nguyen PTV; Yu H; Keller PA
    Interdiscip Sci; 2018 Sep; 10(3):515-524. PubMed ID: 28283929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
    Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
    Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach.
    Agarwal G; Gupta S; Gabrani R; Gupta A; Chaudhary VK; Gupta V
    Bioinformation; 2019; 15(6):439-447. PubMed ID: 31312082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.
    Metz SW; Geertsema C; Martina BE; Andrade P; Heldens JG; van Oers MM; Goldbach RW; Vlak JM; Pijlman GP
    Virol J; 2011 Jul; 8():353. PubMed ID: 21762510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Molecular Surveillance of Chikungunya Virus.
    Fischer C; de Lamballerie X; Drexler JF
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Peptide Binders to Truncated Recombinant Chikungunya Virus Envelope Protein 2 Using Phage Display Technology and Their
    Agarwal G; Gabrani R
    Protein Pept Lett; 2021; 28(5):508-519. PubMed ID: 33121397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jun; ():e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.
    Sahoo B; Gudigamolla NK; Chowdary TK
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.